Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Fraser

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
European Journal of Pharmacology|September 4, 2007
Pharmacological characterization of JNJ-28583867, a histamine H(3) receptor antagonist and serotonin reuptake inhibitorAnn J Barbier, Leah Aluisio, Brian Lord, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2015
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of InsomniaPascal Bonaventure, Jonathan Shelton, Sujin Yun, et al.
Contraception|March 5, 2019
Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluationKristina Gemzell-Danielsson, Regine Sitruk-Ware, Mitchell D Creinin, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2012
Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorderPascal Bonaventure, Christine Dugovic, Michelle Kramer, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonistsEmily M Stocking, Leah Aluisio, John R Atack, et al.
The European Respiratory Journal|April 18, 2020
Population-based case-finding to identify subjects with undiagnosed asthma or COPDMatthew Preteroti, G Alex Whitmore, Katherine L Vandemheen, et al.
Journal of Medicinal Chemistry|December 7, 2017
A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical CandidateChrista C Chrovian, Akinola Soyode-Johnson, Alexander A Peterson, et al.
Respiratory Medicine|July 19, 2022
Disease burden in individuals with symptomatic undiagnosed asthma or COPDFatmah F Alhabeeb, G A Whitmore, Katherine L Vandemheen, et al.
The European Respiratory Journal|March 25, 2022
Derivation and validation of the UCAP-Q case-finding questionnaire to detect undiagnosed asthma and COPDChau Huynh, G A Whitmore, Katherine L Vandemheen, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2019
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase InhibitorRyan M Wyatt, Ian Fraser, Natalie Welty, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Pharmacology|September 4, 2007
Pharmacological characterization of JNJ-28583867, a histamine H(3) receptor antagonist and serotonin reuptake inhibitorAnn J Barbier, Leah Aluisio, Brian Lord, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2015
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of InsomniaPascal Bonaventure, Jonathan Shelton, Sujin Yun, et al.
Contraception|March 5, 2019
Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluationKristina Gemzell-Danielsson, Regine Sitruk-Ware, Mitchell D Creinin, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2012
Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorderPascal Bonaventure, Christine Dugovic, Michelle Kramer, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonistsEmily M Stocking, Leah Aluisio, John R Atack, et al.
The European Respiratory Journal|April 18, 2020
Population-based case-finding to identify subjects with undiagnosed asthma or COPDMatthew Preteroti, G Alex Whitmore, Katherine L Vandemheen, et al.
Journal of Medicinal Chemistry|December 7, 2017
A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical CandidateChrista C Chrovian, Akinola Soyode-Johnson, Alexander A Peterson, et al.
Respiratory Medicine|July 19, 2022
Disease burden in individuals with symptomatic undiagnosed asthma or COPDFatmah F Alhabeeb, G A Whitmore, Katherine L Vandemheen, et al.
The European Respiratory Journal|March 25, 2022
Derivation and validation of the UCAP-Q case-finding questionnaire to detect undiagnosed asthma and COPDChau Huynh, G A Whitmore, Katherine L Vandemheen, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2019
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase InhibitorRyan M Wyatt, Ian Fraser, Natalie Welty, et al.
Pageof 8